Affimed
Founded in 2000 and headquartered in Heidelberg, Baden-Wuerttemberg, Affimed is a clinical-stage immuno-oncology company developing therapies to treat cancer. The company platform provides to a specific patient population.
Last updated on
About Affimed
Founded
2000Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$86MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541714Location
City
HeidelbergState
Baden-WuerttembergCountry
GermanyTech Stack (48)
